Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,217 | -26,772 | -32,522 | -25,906 | -1,864 |
| Depreciation Amortization | 79 | 944 | 644 | 246 | 65 |
| Accounts receivable | 477 | -6,772 | -4,646 | -1,292 | -1,792 |
| Other Working Capital | 6,997 | -406 | -3,892 | -2,419 | -2,833 |
| Other Operating Activity | 1,619 | 14,289 | 26,161 | 21,714 | 2,871 |
| Operating Cash Flow | $-4,045 | $-18,717 | $-14,255 | $-7,657 | $-3,553 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,526 | N/A | -22,507 | -22,807 | -3,832 |
| PPE Investments | -29 | -93 | -59 | -31 | -16 |
| Net Acquisitions | N/A | -14,090 | -14,090 | -14,090 | N/A |
| Purchase Of Investment | N/A | -23,861 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 1,325 | N/A | N/A | N/A |
| Investing Cash Flow | $-17,555 | $-36,719 | $-36,656 | $-36,928 | $-3,848 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,914 | 14,073 | 14,073 | 14,073 | N/A |
| Debt Repayment | -13,217 | -1,322 | -889 | -480 | -10 |
| Common Stock Issued | N/A | 324 | 216 | 216 | N/A |
| Common Stock Repurchased | -3,447 | -4,723 | -4,723 | -4,723 | -4,723 |
| Other Financing Activity | 0 | 0 | -68 | -68 | 0 |
| Financing Cash Flow | $-3,750 | $8,352 | $8,609 | $9,018 | $-4,733 |
| Exchange Rate Effect | 65 | 204 | 15 | N/A | N/A |
| Beginning Cash Position | 65,466 | 112,346 | 112,346 | 112,346 | 112,346 |
| End Cash Position | 40,181 | 65,466 | 70,059 | 76,779 | 100,212 |
| Net Cash Flow | $-25,285 | $-46,880 | $-42,287 | $-35,567 | $-12,134 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,045 | -18,717 | -14,255 | -7,657 | -3,553 |
| Capital Expenditure | -29 | -93 | -59 | -31 | -16 |
| Free Cash Flow | -4,074 | -18,810 | -14,314 | -7,688 | -3,569 |